Quality of Life of the Patient and the Burden of the Caregiver in Progressive Supranuclear Palsy

Recruiting Observational Study
Progressive Supranuclear Palsy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Assistance Publique Hopitaux De Marseille · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease from the parkinsonian syndrome group. PSP is characterised by the association of a non-doparesponsive parkinsonian syndrome with axial signs. The latter predominantly manifest as a psycho-motor slowness, an apathy and frontal executive deficits. Swallowing impairments may additionally provoke life-threatening situations. Tod…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria (patients) Female or male, age ≥ 40 years at the time of onset of symptoms * diagnosis of possible or probable PSP according to the criteria of Litvan (1996b) * agreeing to participate in the study * subject with no severe cognitive impairment (MMS\> 20/30) * subject who does no…
Contacts

ALEXANDRE EUSEBIO, MD

+33 491384360

Alexandre.EUSEBIO@ap-hm.fr

CONTACT